MCP-1and IL-1β expression in the myocardia of two young patients with Type 1 diabetes mellitus and fatal diabetic ketoacidosis.

[1]  J. Köhl,et al.  C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. , 2013, Blood.

[2]  N. Frangogiannis,et al.  IL-1 Induces Proinflammatory Leukocyte Infiltration and Regulates Fibroblast Phenotype in the Infarcted Myocardium , 2013, The Journal of Immunology.

[3]  D. Hannon,et al.  Increased Systemic Th17 Cytokines Are Associated with Diastolic Dysfunction in Children and Adolescents with Diabetic Ketoacidosis , 2013, PloS one.

[4]  K. Mills,et al.  The role of inflammasome‐derived IL‐1 in driving IL‐17 responses , 2013, Journal of leukocyte biology.

[5]  H. Duff,et al.  The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin‐1β , 2013, Experimental physiology.

[6]  Sreedhar Bodiga,et al.  Advanced glycation end products: role in pathology of diabetic cardiomyopathy , 2013, Heart Failure Reviews.

[7]  T. Ueland,et al.  Inflammatory Cytokines in Heart Failure: Mediators and Markers , 2012, Cardiology.

[8]  J. Olefsky,et al.  The cellular and signaling networks linking the immune system and metabolism in disease , 2012, Nature Medicine.

[9]  I. Papassotiriou,et al.  Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). , 2011, Endocrine journal.

[10]  N. Rose.  Critical cytokine pathways to cardiac inflammation. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[11]  L. Sechi,et al.  Oxidative stress is activated by free fatty acids in cultured human hepatocytes. , 2011, Metabolic syndrome and related disorders.

[12]  G. Voros,et al.  Spontaneous rupture of a papillary muscle in acute myocarditis , 2011, Acta cardiologica.

[13]  A. Rudich,et al.  Adolescent BMI trajectory and risk of diabetes versus coronary disease. , 2011, The New England journal of medicine.

[14]  B. Williams,et al.  Interferon-stimulated genes and their protein products: what and how? , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[15]  S. Kato,et al.  A case of fulminant type 1 diabetes mellitus accompanied by myocarditis. , 2011, Endocrine journal.

[16]  S. Blankenberg,et al.  Inflammatory markers and cardiovascular risk in the metabolic syndrome. , 2011, Frontiers in bioscience.

[17]  I. Jialal,et al.  Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. , 2011, American journal of physiology. Endocrinology and metabolism.

[18]  F. Ismail-Beigi,et al.  Endothelin-1 Increases Collagen Accumulation in Renal Mesangial Cells by Stimulating a Chemokine and Cytokine Autocrine Signaling Loop* , 2010, The Journal of Biological Chemistry.

[19]  J. Joven,et al.  Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (or CCL2) in the Regulation of Metabolism , 2010, Mediators of inflammation.

[20]  K. Berneis,et al.  Pre‐clinical diabetic cardiomyopathy: prevalence, screening, and outcome , 2010, European journal of heart failure.

[21]  M. Powell,et al.  Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes. , 2010, American journal of physiology. Heart and circulatory physiology.

[22]  A. Doseff,et al.  Monocytes and Macrophages Regulate Immunity through Dynamic Networks of Survival and Cell Death , 2010, Journal of Innate Immunity.

[23]  S. Alway,et al.  Enhanced apoptotic propensity in diabetic cardiac mitochondria: influence of subcellular spatial location. , 2010, American journal of physiology. Heart and circulatory physiology.

[24]  Małgorzata Wójcik,et al.  Left Ventricular Diastolic Dysfunction in Adolescents with Type 1 Diabetes Reflects the Long- but Not Short- Term Metabolic Control , 2010, Journal of pediatric endocrinology & metabolism : JPEM.

[25]  Z. Turk,et al.  Glycotoxines, carbonyl stress and relevance to diabetes and its complications. , 2010, Physiological research.

[26]  A. Sanz,et al.  Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes. , 2009, American journal of physiology. Heart and circulatory physiology.

[27]  S. Salami,et al.  Cardioprotective effect of vitamin E: rescues of diabetes-induced cardiac malfunction, oxidative stress, and apoptosis in rat. , 2009, Journal of diabetes and its complications.

[28]  Shi-Yan Li,et al.  Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up‐regulation contribute to the onset of diabetic cardiomyopathy , 2009, Journal of cellular and molecular medicine.

[29]  P. Kolattukudy,et al.  Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. , 2009, Clinical science.

[30]  N. Frangogiannis,et al.  Chemokines and cardiac fibrosis. , 2009, Frontiers in bioscience.

[31]  S. Stamatovic,et al.  Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis , 2009, Brain Research.

[32]  T. Ohe,et al.  Expression of monocyte chemoattractant protein-1 in idiopathic dilated cardiomyopathy. , 2008, International journal of cardiology.

[33]  A. Ahmann,et al.  The Impact of Diabetes and Associated Cardiometabolic Risk Factors on Members: Strategies for Optimizing Outcomes , 2008, Journal of managed care pharmacy : JMCP.

[34]  Carol Forsblom,et al.  Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes , 2008, Annals of medicine.

[35]  Stefano Geuna,et al.  Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. , 2008, Endocrinology.

[36]  N. Rose,et al.  Pathogenesis of myocarditis and dilated cardiomyopathy. , 2008, Advances in immunology.

[37]  E. Abel,et al.  Diabetic cardiomyopathy revisited. , 2007, Circulation.

[38]  S. Russell,et al.  Nonischemic cardiomyopathy associated with autoimmune polyglandular syndrome type II. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[39]  K. Maiese,et al.  Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. , 2007, Current neurovascular research.

[40]  L. Cai,et al.  Cell death and diabetic cardiomyopathy , 2007, Cardiovascular Toxicology.

[41]  R. Lanes,et al.  Coronary artery calcification, serum lipids, lipoproteins, and peripheral inflammatory markers in adolescents and young adults with type 1 diabetes. , 2006, The Journal of pediatrics.

[42]  R. Schulz,et al.  Detection of specific nitrotyrosine-modified proteins as a marker of oxidative stress in cardiovascular disease. , 2006, American journal of physiology. Heart and circulatory physiology.

[43]  C. Palmeira,et al.  Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. , 2006, Toxicology and applied pharmacology.

[44]  I. Német,et al.  Elevated level of methylglyoxal during diabetic ketoacidosis and its recovery phase. , 2006, Diabetes & metabolism.

[45]  M. Kodama,et al.  Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis. , 2005, Cardiovascular research.

[46]  C. Burek,et al.  Complement activation in diabetic ketoacidosis and its treatment. , 2005, Clinical immunology.

[47]  S. Kosanke,et al.  Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells. , 2005, The American journal of pathology.

[48]  M. Schubert,et al.  Autoimmune polyglandular syndrome associated with idiopathic giant cell myocarditis. , 2005, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[49]  C. Long,et al.  The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. , 2005, Annual review of pharmacology and toxicology.

[50]  R. Dalton,et al.  Plasma C-reactive protein levels in severe diabetic ketoacidosis. , 2003, Annals of clinical and laboratory science.

[51]  J. Waller,et al.  Cytokine response to diabetic ketoacidosis and its treatment. , 2003, Clinical immunology.

[52]  R. Mehta,et al.  Diabetic ketoacidosis and its treatment increase plasma 3-deoxyglucosone. , 2003, Clinical biochemistry.

[53]  J. Fernández-Real,et al.  Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.

[54]  W. Schaper,et al.  Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation. , 2003, Cardiovascular research.

[55]  D. Hess,et al.  Acetoacetate increases expression of intercellular adhesion molecule-1 (ICAM-1) in human brain microvascular endothelial cells , 2002, Neuroscience Letters.

[56]  K. Motoyoshi,et al.  Interleukin‐10 differently regulates monocyte chemoattractant protein‐1 gene expression depending on the environment in a human monoblastic cell line, UG3 , 2002, Journal of leukocyte biology.

[57]  U. Das.  Is insulin an endogenous cardioprotector? , 2002, Critical care.

[58]  W. Hoffman,et al.  Lipid peroxidation and antioxidant vitamins prior to, during, and after correction of diabetic ketoacidosis. , 2002, Journal of diabetes and its complications.

[59]  Yoshiyuki Kobayashi,et al.  Levels of MCP-1 and GM-CSF mRNA Correlated with Inflammatory Cytokines mRNA Levels in Experimental Autoimmune Myocarditis in Rats , 2002, Autoimmunity.

[60]  I. Norota,et al.  Inotropic response of rabbit ventricular myocytes to endothelin-1: difference from isolated papillary muscles. , 2001, American journal of physiology. Heart and circulatory physiology.

[61]  O. Sejersted,et al.  Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes , 2001, Basic Research in Cardiology.

[62]  A. Aljada,et al.  Insulin Inhibits NFκB and MCP-1 Expression in Human Aortic Endothelial Cells , 2001 .

[63]  A. Maseri,et al.  Myocardial Cell Death in Human Diabetes , 2000, Circulation research.

[64]  P. Kolattukudy,et al.  Monocyte chemotactic protein 1 upregulates IL-1beta expression in human monocytes. , 2000, Biochemical and biophysical research communications.

[65]  K. Ohmori,et al.  Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. , 2000, Circulation.

[66]  S. Grundy,et al.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 1999, Circulation.

[67]  C. Isales,et al.  Acetoacetate and β-Hydroxybutyrate Differentially Regulate Endothelin-1 and Vascular Endothelial Growth Factor in Mouse Brain Microvascular Endothelial Cells , 1999 .

[68]  S. Jain,et al.  Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. , 1998, Free radical biology & medicine.

[69]  J. Kjekshus,et al.  Elevated circulating levels of C-C chemokines in patients with congestive heart failure. , 1998, Circulation.

[70]  C. Orosz,et al.  Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. , 1998, The American journal of pathology.

[71]  P. Cerutti,et al.  High Glucose Induces Antioxidant Enzymes in Human Endothelial Cells in Culture: Evidence Linking Hyperglycemia and Oxidative Stress , 1996, Diabetes.

[72]  A. Nagasaka,et al.  A Case of Myocarditis Associated With IDDM , 1996, Diabetes Care.

[73]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[74]  S. Zarich,et al.  Severity of coronary artery disease in young patients with insulin-dependent diabetes mellitus. , 1991, American heart journal.

[75]  T. Riggs,et al.  Doppler echocardiographic evaluation of left ventricular diastolic function in adolescents with diabetes mellitus. , 1990, The American journal of cardiology.